Repro Med Systems, Inc. (KRMD) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
KORU Medical Systems Announces 2020 First Quarter Financial Results
May 4, 2020 4:52 PM EDTQ1 2020 Summary
Net sales rose 27% to $6.3 million Gross margin of 60% (62% excluding inventory obsolescence charge) Net income improved to $0.4 million, or $0.01 per share Adjusted EBITDA increased 38% to $1.3 million COVID-19 UpdateCHESTER, N.Y.--(BUSINESS WIRE)-- Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (KORU Medical or the Company) today announced financial results for the first quarter ended March 31, 2020 (Q1 2020).
We reported a strong Q1 2020 with net sales, net income, and Adjusted EBITDA rising from Q1 2019, said Don Pettigrew, President and CEO. We... More
